China Kangtai Cactus Biotech Announces Preliminary Year End 2006 Results

China Kangtai Cactus Biotech Announces Preliminary Year End 2006 Results

January 23, 2007

Net Sales Increase 110%; Net Income Grows Over 300%


    HARBIN, China, Jan. 23 /Xinhua-PRNewswire/ -- China
Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a
vertically integrated grower, developer, manufacturer and
marketer of a variety of cactus-based consumer products,
today reported preliminary, unaudited results for the year
ended December 31, 2006.  All estimated results reported
are in U.S. dollars.  The preliminary unaudited results
indicate that net sales for the year-ended December 31,
2006 will increase to approximately $17 million, which
would represent an increase of approximately 110% as
compared to net sales of $8 million for the year ended
December 31, 2005.  The preliminary unaudited results also
indicate that net income from operations for the year ended
December 31, 2006 will increase to approximately $3.4
million, which would represent an increase of more than
300% over net income from operations of $795,000 for the
year ended December 31, 2005.  Final audited results are
expected to be reported in mid-February.

    Jinjiang Wang, Chief Executive Officer of China Kangtai
Cactus Biotech commented, "Our projected revenue growth
for 2006 is attributed to a growing demand for our high
quality cactus-based consumer products throughout China, as
well as our continuing efforts to expand our growing
distribution network."

    Wang concluded, "Our Company remains focused on
creating more product categories and lines for distribution
and enhancing our sales support as well as our inventory
management systems.  With 17 product patents and 15 pending
approval, China Kangtai is the dominant company in the
cactus-based consumer product sector."

    About China Kangtai Cactus Bio-Tech Inc.

    China Kangtai Cactus Bio-Tech Inc. is market-leading
cactus grower and producer of cactus-related products with
over 520 acres of plants and an active R&D group that
holds 17 product patents and is seeking another 15 in a
variety of product categories. Kangtai's high-quality
products are sold throughout China through a growing
distribution network that includes franchised,
company-owned and third party stores, as well as store
counters in supermarkets, department stores, hotels,
restaurants and malls.

    Cautionary Statement Regarding Forward Looking
Information

    This press release contains forward-looking information
about China Kangtai Cactus Bio-tech that is intended to be
covered by the safe harbor for forward-looking statements
provided by the Private Securities Litigation Reform Act of
1995. Forward-looking statements are statements that are not
historical facts. These statements can be identified by the
use of forward-looking terminology such as
"believe," "expect," "may,"
"will," "should," "project,"
"plan," "seek," "intend," or
"anticipate" or the negative thereof or
comparable terminology, and include discussions of
strategy, and statements about industry trends and China
Kangtai Cactus Bio-tech future performance, operations and
products.

    This forward-looking information should be considered
only in connection with "Risk Factors" in China
Kangtai Cactus Bio-tech's quarterly report on Form 10-Q
filed with the SEC on November 14, 2006, and its other
current and periodic reports filed with the SEC. China
Kangtai Cactus Bio-tech assumes no obligations to update
any forward-looking statements or information set forth in
this press release.

    For more information, please contact:

     Ren Hu
     China Kangtai Cactus Bio-tech, Inc.
     Tel:   [phone]
     Email: [e-mail]                              

     Adam Friedman
     Adam Friedman Associates
     Tel:   [phone] ext. 18
     Email: [e-mail] 


SOURCE  China Kangtai Cactus Biotech, Inc.